Literature DB >> 17985266

Urinary epidermal and insulin-like growth factor excretion in autistic children.

B Anlar1, F Oktem, B Bakkaloglu, M Haliloglu, H Oguz, F Unal, B Pehlivanturk, B Gokler, C Ozbesler, N Yordam.   

Abstract

Growth factors have been implicated in the pathogenesis of autism. We have investigated daily urinary excretion of insulin-like growth factor-1 (IGF-1), epidermal growth factor, and insulin-like growth factor binding protein-3 in autistic children (n=34, age 2-5 years) and age-matched control children (n=29). The mean urinary IGF-1 level was lower in the autism group than the control group (p=0.03). Height was normal. These findings suggest altered IGF-1 metabolism in young autistic children. The cause-effect relationship should be examined by longitudinal studies and insulin-like growth factor provocation tests.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17985266     DOI: 10.1055/s-2007-990282

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  10 in total

1.  Increased serum levels of epidermal growth factor in children with autism.

Authors:  Elvan Işeri; Esra Güney; Mehmet F Ceylan; Ayşegül Yücel; Arzu Aral; Sahin Bodur; Sahnur Sener
Journal:  J Autism Dev Disord       Date:  2011-02

Review 2.  Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants.

Authors:  Nikhat J Siddiqi; Maria de Lourdes Pereira; Bechan Sharma
Journal:  Mol Neurobiol       Date:  2022-03-29       Impact factor: 5.590

3.  Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in children with autism spectrum disorder.

Authors:  Zheng Li; Gui-Yuan Xiao; Chun-Yan He; Xia Liu; Xin Fan; Yan Zhao; Nian-Rong Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-02-15

4.  Comparison of Serum VEGF, IGF-1, and HIF-1α Levels in Children with Autism Spectrum Disorder and Healthy Controls.

Authors:  Fulya Şimşek; Ümit Işık; Evrim Aktepe; Faruk Kılıç; Fevziye Burcu Şirin; Mustafa Bozkurt
Journal:  J Autism Dev Disord       Date:  2021-01-03

5.  The dwarf phenotype in GH240B mice, haploinsufficient for the autism candidate gene Neurobeachin, is caused by ectopic expression of recombinant human growth hormone.

Authors:  Kim Nuytens; Krizia Tuand; Quili Fu; Pieter Stijnen; Vincent Pruniau; Sandra Meulemans; Hugo Vankelecom; John W M Creemers
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

Review 6.  Insulin-Like Growth Factor 1 and Related Compounds in the Treatment of Childhood-Onset Neurodevelopmental Disorders.

Authors:  Cyrus Vahdatpour; Adam H Dyer; Daniela Tropea
Journal:  Front Neurosci       Date:  2016-09-30       Impact factor: 4.677

Review 7.  Insulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children.

Authors:  Raili Riikonen
Journal:  Int J Mol Sci       Date:  2017-09-26       Impact factor: 5.923

8.  Peripheral blood neurotrophic factor levels in children with autism spectrum disorder: a meta-analysis.

Authors:  Shu-Han Liu; Xiao-Jie Shi; Fang-Cheng Fan; Yong Cheng
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

9.  BDNF, proBDNF and IGF-1 serum levels in naïve and medicated subjects with autism.

Authors:  Maria de Los Angeles Robinson-Agramonte; Bernadeta Michalski; Belkis Vidal-Martinez; Leyanis Ramos Hernández; Mabel Whilby Santiesteban; Margaret Fahnestock
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

10.  Consumption of Breast Milk Is Associated with Decreased Prevalence of Autism in Fragile X Syndrome.

Authors:  Cara J Westmark
Journal:  Nutrients       Date:  2021-05-24       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.